10 Hep C Stocks on Wall Street's Watch List

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Most Viewed Portfolios

View All

Articles

5 Rocket Stocks to Buy for August Gains

07.28.14 | 09:57 AM

BALTIMORE (Stockpickr) -- It may be hard to believe, but August trading kicks off on Friday. That means that investors need to be buckling in for t...

3 Stocks Spiking on Big Volume

07.28.14 | 07:27 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter